Steven Kelly
Chief Executive Officer at CARISMA THERAPEUTICS, INC.
Net worth: 1 234 $ as of 2024-03-30
Profile
Steven Kelly is the founder of CTx Operations, Inc. (founded in 2018) where he holds the title of President, Chief Executive Officer & Director.
He is currently the President, Chief Executive Officer & Director at Carisma Therapeutics, Inc. (since 2018) and an Independent Director at Artelo Biosciences, Inc. (since 2017).
Previously, he held the position of President & Chief Executive Officer at Innovive Pharmaceuticals, Inc. (2004-2010), President & Chief Executive Officer at Pinteon Therapeutics, Inc. (2014-2015), Chief Executive Officer at Theracrine, Inc. (2011-2012), and Chief Commercial Officer at BioVex, Inc. He also founded Kelly Bioconsulting LLC (2012-2018) where he served as Principal.
Mr. Kelly holds an MBA from Cornell University and an undergraduate degree from the University of Oregon.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARTELO BIOSCIENCES INC
0.03% | 2024-03-21 | 834 ( 0.03% ) | 1 234 $ | 2024-03-30 |
| 2024-01-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Steven Kelly active positions
| Companies | Position | Start |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Director/Board Member | 2017-05-01 |
| CARISMA THERAPEUTICS, INC. | Chief Executive Officer | 2018-01-31 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Founder | 2018-04-22 |
Former positions of Steven Kelly
| Companies | Position | End |
|---|---|---|
Kelly Bioconsulting LLC
 Kelly Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services Kelly Bioconsulting LLC provides business consulting services. The private company is based in Boulder. | Corporate Officer/Principal | 2017-12-31 |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Chief Executive Officer | 2015-06-30 |
Theracrine, Inc.
 Theracrine, Inc. BiotechnologyHealth Technology Theracrine, Inc. develops anti-metastatic drugs for cancer therapeutics. It provides scientific and technological services as well as research and design relating thereto. The company was founded by David A. Berry, Noubar B. Afeyan, Robert A. Weinberg, Joan Massagué and Douglas Hanahan in 2006 and is headquartered in Cambridge, MA. | Chief Executive Officer | 2012-07-31 |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | President | 2010-10-10 |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Corporate Officer/Principal | - |
Training of Steven Kelly
| Cornell University | Masters Business Admin |
| University of Oregon | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
Pinteon Therapeutics, Inc.
Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Health Technology |
| Artelo Biosciences, Inc. | |
Theracrine, Inc.
Theracrine, Inc. BiotechnologyHealth Technology Theracrine, Inc. develops anti-metastatic drugs for cancer therapeutics. It provides scientific and technological services as well as research and design relating thereto. The company was founded by David A. Berry, Noubar B. Afeyan, Robert A. Weinberg, Joan Massagué and Douglas Hanahan in 2006 and is headquartered in Cambridge, MA. | Health Technology |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Kelly Bioconsulting LLC
Kelly Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services Kelly Bioconsulting LLC provides business consulting services. The private company is based in Boulder. | Commercial Services |
- Stock Market
- Insiders
- Steven Kelly
